Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia

Autor:	Mounzer Agha, Matthew J. Lim, Aya Agha, Seah H. Lim, Annie Im, Michael Boyiadzis, Stanley S. Marks, Alison R. Sehgal, Robert L. Redner, Kathleen A. Dorritie, Anastasios Raptis, Jing Z. Hou
Rok vydání:	2017
Předmět:	0301 basic medicine Oncology Male Cancer Research medicine.medical_specialty Myeloid Newly diagnosed Disease-Free Survival 03 medical and health sciences 0302 clinical medicine Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Survival rate Aged business.industry Induction chemotherapy Myeloid leukemia Hematology General Medicine Induction Chemotherapy medicine.disease Survival Rate Regimen Leukemia Leukemia Myeloid Acute 030104 developmental biology medicine.anatomical_structure Hypomethylating agent 030220 oncology & carcinogenesis Female business
Zdroj:	Hematological oncology. 36(2)
ISSN:	1099-1069
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44408e26f96327983db3442120ef68bb https://pubmed.ncbi.nlm.nih.gov/28664979 Zobrazit plný text záznamu Plný text